GLP-1 Weight Loss in Lansing, MI: What It Costs When No One Will Tell You the Price

What Michigan Medicaid now covers for weight-loss GLP-1s

Michigan Medicaid covers GLP-1s such as Wegovy, Zepbound, Saxenda and liraglutide for obesity alone only in narrow cases. For dates of service on or after January 1, 2026, coverage for that use, including continuation requests, was reduced, and approval requires prior authorization showing the patient is morbidly obese, has documented failure of all other clinically appropriate weight-loss interventions (including preferred anti-obesity agents), and that the drug is considered only to avert higher-cost bariatric surgery ⁹. The state letter names no BMI number; Aetna's 2026 criteria for its Michigan HIDE plan (for people enrolled in both Medicare and Medicaid) give a baseline BMI of 40 or higher as an example of morbid obesity ¹³. Authorizations granted before January 1, 2026 are honored for the remainder of the authorization period ⁹¹².

Coverage for GLP-1s requested for other existing indications, such as type 2 diabetes, is not changing ⁹. Priority Health, a Michigan Medicaid health plan, says its Wegovy and Zepbound criteria include non-weight-loss indications such as reducing major adverse cardiovascular events or severe obstructive sleep apnea, with prior authorization required for all indications ¹². Plan rules vary, so anyone on Michigan Medicaid in Lansing should check with their Medicaid health plan for the criteria that apply.

What GLP-1 care costs in Lansing today

Aesthetics Medical Spa, at 1568 Lake Lansing Road, runs a dedicated semaglutide and tirzepatide page (which misspells tirzepatide as "Trizepatide") and, confirmed by direct fetch on 2026-08-28, carries no dollar figure anywhere on it. Its own words: "Several factors will determine the cost of Semaglutide and Trizepatide treatments in Lansing. The best way to find out how much this treatment will cost you is to meet with Dr. Ronan for a consultation." ¹⁰

University of Michigan Health-Sparrow's Lansing Bariatrics & Weight Management program is the other local option, and it is a bariatric-surgery service framed entirely around insurance, "typically covered by most insurances," with a payer list. No GLP-1 medication and no self-pay or cash price appears anywhere on the page. Checked 2026-08-28 ¹¹.

Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide, both on 12-month plans. It is published up front, with nothing to negotiate at a consultation.

A low-income shortage designation spanning two counties

Ingham and Eaton counties carry an active HRSA Primary Care HPSA for the low-income population, "LI-Greater Lansing SA" (ID 1262071134, score 14, population-to-provider ratio 5,535:1, designation population 107,273), spanning both counties' rural and non-rural tracts. Two facility-based Primary Care HPSAs sit inside Lansing itself: the County of Ingham Health Department FQHC (ID 126999264Y, score 17, service population 58,661) and Care Free Medical Inc., an FQHC Look-Alike free clinic (ID 1262293456, score 14, service population 150,108). The shortage is concentrated in the low-income population specifically, not city-wide, and is current as of the HRSA file's Aug 27, 2026 update ⁸.

HRSA does not designate shortage areas for endocrinology or obesity medicine, only primary care, dental, and mental health, so no federal shortage ratio exists for that specialty here. That is a data gap, not a finding of adequate access ⁸.

With the hospital program priced through insurance and the one independent med spa gating cost behind a consultation, telehealth is the only route in Lansing to a transparent, published price. See the Michigan GLP-1 overview for statewide context.